🏥 治験ポータル
← 治験一覧に戻る

冠動脈疾患を有する2型糖尿病患者におけるコルヒチンの用量探索試験

基本情報

NCT ID
NCT03376698
ステータス
完了
試験のフェーズ
第2相
試験タイプ
介入
目標被験者数
54
治験依頼者名
University of the Ryukyus

概要

This study is designed to investigate dose-dependent effects of low dose colchicine on inflammatory responses, endothelial function in type 2 diabetic patients with coronary artery disease and leukocyte activation. This study also tested the relationship between doses and safety issue such as incidence of diarrhea. Eligible patients will be randomly allocated to three treatment group: colchicine at 0.5mg per day, 0.25mg per day or placebo for 12 weeks in a double blind , parallel group design. High sensitive-CRP at 4 weeks as primary end point and flow mediated vasodilatation at 12 weeks as the secondary end point will be measured.

対象疾患

ColchicineDiabetes Mellitus, Type 2Coronary Artery DiseaseWhite Blood CellInflammationDiarrhea

介入

Colchicine 0.5 mg(DRUG)
Colchicine 0.25 mg(DRUG)
Placebo(DRUG)

依頼者(Sponsor)

実施施設 (5)

Urasoe Sogo Hospital

Okinawa, Japan

Dokkyo Medical University Nikko Medical Center

Tochigi, Japan

広島大学病院

Hiroshima, Japan

北里大学病院

Kanagawa, Japan

昭和医科大学病院

Tokyo, Japan